Cosopt
INDICATIONS
COSOPT is indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension, open-angle glaucoma, pseudoexfoliative glaucoma or other secondary open-angle glaucomas when concomitant therapy is appropriate.
DOSAGE AND ADMINISTRATION
The dose is one drop of COSOPT in the affected eye(s) two times daily.
When substituting COSOPT for another ophthalmic antiglaucoma agent(s), discontinue the other agent(s) after proper dosing on one day, and start COSOPT on the next day.
If another topical ophthalmic agent is being used, COSOPT and the other agent should be administered at least ten minutes apart.
Safety and efficacy in pediatric patients below the age of 2 years have not been established. (For information regarding use in pediatric patients ≥ 2 years of age see Pediatric Use)
HOW SUPPLIED
Availability
Cosopt® 2%, 0.5% (dorzolamide hydrochloride and timolol maleate opthalmic solution, MSD) is available in 5ml dispenser.
COSOPT is a clear, colorless to nearly colorless, slightly viscous solution.
Storage
COSOPT Ophthalmic Solution:
Store at 15-30°C (59-86°F). Protect from light.
MERCK & CO., Inc., Whitehouse Station, NJ, USA. FDA rev date: 8/9/2006
Generic Name: Dorzolamide Hydrochloride-Timolol Maleate
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.
Health Extras
Glaucoma Laser Treatment
Glaucoma is a sight-stealing condition caused by pressure in the eye. Now patients are finding results through glaucoma laser treatment. See more WebMD Videos »
Cosopt
Health Resources
Updated & New
RxList does not provide medical advice, diagnosis or treatment.